Fidelity Advisor Health Care Fund - Class C FHCCX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 42.57  /  +0.42 %
  • Total Assets 3.4B
  • Adj. Expense Ratio
    1.710%
  • Expense Ratio 1.700%
  • Distribution Fee Level Low
  • Share Class Type Level Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 74%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0

Morningstar’s Analysis FHCCX

Will FHCCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still an exceptional source of healthcare exposure for the long term.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Fidelity Health Care Sector remains in the hands of a topnotch team that employs a sound and differentiated approach. The strategy, which includes two mutual funds, retains its High People and Above Average Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FHCCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 39.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

7.10 237M
Healthcare

Thermo Fisher Scientific Inc

6.65 222M
Healthcare

Danaher Corp

6.61 221M
Healthcare

UnitedHealth Group Inc

3.20 107M
Healthcare

Johnson & Johnson

3.06 102M
Healthcare

AbbVie Inc

2.82 94M
Healthcare

Natera Inc

2.75 92M
Healthcare

Merck & Co Inc

2.56 86M
Healthcare

West Pharmaceutical Services Inc

2.54 85M
Healthcare

argenx SE ADR

2.28 76M
Healthcare

Sponsor Center